Hints from the skin beneath: Vitiligo in Vogt-Koyanagi-Harada disease

被引:2
|
作者
Lim, Jo Anne [1 ]
Tan, Wooi Chiang [2 ]
Nor, Norazirah Md [3 ]
机构
[1] Univ Sains Malasia, Hosp USM, Sch Med Sci, Dept Internal Med, Gelugor, Kelantan, Malaysia
[2] Hosp Pulau Pinang, Dept Dermatol, George Town, Malaysia
[3] Univ Kebangsaan Malaysia, Fac Med, Kuala Lumpur, Malaysia
关键词
Autoimmune disease; uveitis; vitiligo; Vogt-Koyanagi-Harada disease; NIVOLUMAB ANTI-PD-1 ANTIBODY; PROGNOSTIC-FACTORS; UVEITIS; MELANOMA; IPILIMUMAB; DIAGNOSIS; REVERSAL; OUTCOMES;
D O I
10.4103/ds.ds_23_22
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Vogt-Koyanagi-Harada disease (VKHD) is a major vision-threatening autoimmune disease. One of its associated features is vitiligo. Little study has been done on the association between vitiligo and the disease activity of VKHD. The authors searched available literature on the relationship between vitiligo and ophthalmic disease activity in VKHD in terms of pathogenesis, clinical presentations, risk factors as well as disease activity. Among the findings is that early treatment of VKHD may be associated with full recovery. The reversal of poliosis and vitiligo is associated with the remission of uveitis, but the reverse does not hold true, whereby the worsening of vitiligo may not reflect the worsening of uveitis. It is also found that there may be an association between immunotherapy and Vogt-Koyanagi-Harada-like disease. In summary, vitiligo is an immune-mediated cutaneous manifestation which may contribute to diagnostic and treatment strategies in VKHD. Future research on genetic differences in vitiligo is still needed and may contribute to specific monitoring and therapeutic approach in this disease.
引用
收藏
页码:78 / +
页数:9
相关论文
共 50 条
  • [21] Tofacitinib in Vogt-Koyanagi-Harada disease
    Majumder, Parthopratim Dutta
    Shah, Amravi
    Kaushik, Viswanath
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (09) : 1938 - 1939
  • [22] Vogt-Koyanagi-Harada Disease and COVID
    Manni, Priscilla
    Saturno, Maria Carmela
    Accorinti, Massimo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [23] Vogt-Koyanagi-Harada disease in children
    Abu El-Asrar, A. M.
    Al-Kharashi, A. S.
    Aldibhi, H.
    Al-Fraykh, H.
    Kangave, D.
    EYE, 2008, 22 (09) : 1124 - 1131
  • [24] Vogt-Koyanagi-Harada disease in children
    A M Abu El-Asrar
    A S Al-Kharashi
    H Aldibhi
    H Al-Fraykh
    D Kangave
    Eye, 2008, 22 : 1124 - 1131
  • [25] Pathology of Vogt-Koyanagi-Harada disease
    Rao N.A.
    International Ophthalmology, 2007, 27 (2-3) : 81 - 85
  • [26] HLA AND VOGT-KOYANAGI-HARADA DISEASE
    OHNO, S
    ACTA OPHTHALMOLOGICA, 1984, : 46 - 49
  • [27] Treatment of Vogt-Koyanagi-Harada Disease
    Alaql, Musab K.
    Akinfe, Akinwale A.
    AlNour, Mohammed K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (07)
  • [28] Vogt-Koyanagi-Harada disease in Spain
    Arriola-Villalobos, Pedro
    Moll-Udina, Aina
    Carrasco-Lopez-Brea, Mario
    Sacristan, Cristina
    Jose Capella, Maria
    Peiteado, Diana
    Garrote-Llorden, Ana
    Albert Fort, Mara
    Jodar Marquez, Margarita
    Gonzalez Guijarro, Juan Jacobo
    Demetrio-Pablo, Rosalia
    Sanchez Sevilla, Juan Luis
    Carreno, Ester
    Gonzalez-Lopez, Julio
    Miguel-Escuder, Lucia
    Cuadros, Carlos
    Diaz-Valle, David
    Adan, Alfredo
    Benitez del Castillo, Jose M.
    Fonollosa, Alejandro
    Cordero, Miguel
    Martinez Costa, Lucia
    Blanco-Alonso, Ricardo
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (03) : 1547 - 1554
  • [29] Vogt-Koyanagi-Harada Disease in Thailand
    Yodmuang, Tosaporn
    Rothova, Aniki
    Kunavisarut, Paradee
    Pathanapitoon, Kessara
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2012, 20 (06) : 419 - 422
  • [30] The skin, the eyes, and the ears in Vogt-Koyanagi-Harada disease (VKHD)
    Komal Ejaz
    Kinanah Yaseen
    Clinical Rheumatology, 2024, 43 : 817 - 818